ePrivacy and GPDR Cookie Consent by TermsFeed Generator

Search












The lists contain medicinal products or product categories subject to prescription which shall not bear the safety features (White list) and medicinal products or product categories not subject to prescription which shall bear the safety features (Black list)
Number of records: 144
Name of the medicinal product Supplement
SÚKL code Registration Number SPC ? PIL ? ATC group MA status ?
GLIKLAZID ACTAVIS 60MG TBL MRL 180 I
0206446 18/ 251/15-C gliklazida.pdf gliklazida.pdf A10BB09 R
GLIKLAZID ACTAVIS 60MG TBL MRL 10 II
0206447 18/ 251/15-C gliklazida.pdf gliklazida.pdf A10BB09 R
GLIKLAZID ACTAVIS 60MG TBL MRL 14 II
0206448 18/ 251/15-C gliklazida.pdf gliklazida.pdf A10BB09 R
GLIKLAZID ACTAVIS 60MG TBL MRL 28 II
0206449 18/ 251/15-C gliklazida.pdf gliklazida.pdf A10BB09 R
GLIKLAZID ACTAVIS 60MG TBL MRL 30 II
0206450 18/ 251/15-C gliklazida.pdf gliklazida.pdf A10BB09 R
GLIKLAZID ACTAVIS 60MG TBL MRL 56 II
0206451 18/ 251/15-C gliklazida.pdf gliklazida.pdf A10BB09 R
GLIKLAZID ACTAVIS 60MG TBL MRL 60 II
0206452 18/ 251/15-C gliklazida.pdf gliklazida.pdf A10BB09 R
GLIKLAZID ACTAVIS 60MG TBL MRL 90 II
0206453 18/ 251/15-C gliklazida.pdf gliklazida.pdf A10BB09 R
GLIKLAZID ACTAVIS 60MG TBL MRL 120 II
0206454 18/ 251/15-C gliklazida.pdf gliklazida.pdf A10BB09 R
GLIKLAZID ACTAVIS 60MG TBL MRL 180 II
0206455 18/ 251/15-C gliklazida.pdf gliklazida.pdf A10BB09 R
GLIKLAZID ACTAVIS 60MG TBL MRL 90 III
0206456 18/ 251/15-C gliklazida.pdf gliklazida.pdf A10BB09 R
GLIKLAZID ACTAVIS 60MG TBL MRL 120 III
0206457 18/ 251/15-C gliklazida.pdf gliklazida.pdf A10BB09 R
GLIKLAZID ACTAVIS 60MG TBL MRL 180 III
0206458 18/ 251/15-C gliklazida.pdf gliklazida.pdf A10BB09 R
GLIKLAZID ACTAVIS 30MG TBL MRL 10 I
0206417 18/ 250/15-C gliklazida.pdf gliklazida.pdf A10BB09 R
GLIKLAZID ACTAVIS 30MG TBL MRL 14 I
0206418 18/ 250/15-C gliklazida.pdf gliklazida.pdf A10BB09 R
GLIKLAZID ACTAVIS 30MG TBL MRL 28 I
0206419 18/ 250/15-C gliklazida.pdf gliklazida.pdf A10BB09 R
GLIKLAZID ACTAVIS 30MG TBL MRL 120 IV
0254317 18/ 250/15-C gliklazida.pdf gliklazida.pdf A10BB09 R
GLYCLADA 60MG TBL MRL 180 II
0188473 18/ 321/13-C glyclada.pdf glyclada.pdf A10BB09 R
GLYCLADA 60MG TBL MRL 84 I
0188467 18/ 321/13-C glyclada.pdf glyclada.pdf A10BB09 R
GLYCLADA 60MG TBL MRL 120 I
0188471 18/ 321/13-C glyclada.pdf glyclada.pdf A10BB09 R

‹‹ ‹ 1 2 3 4 5 6 7 8 › ››

Medicinal products reimbursed from health insurance are blue-tinged and marked with sign.

Medicinal products on the Czech market in line with periodical report from wholesalers in last 3 months (with monthly distance) are sign and are typed in bold

Last update of registration information: 17. May 2022 at 01:08
Last update of price and payment data: 30. April 2022 at 01:09